Head of Global Business Development and Licensing @ (May 2024 - July 2026)
Senior Vice President Business Development @ (January 2023 - June 2024)
Executive Vice President Business Development @ HUYABIO International (December 2021 - May 2024)
Senior Director of Global Business Development @ (December 2020 - December 2021)
Director of Commercial Strategy, Cell and Gene Therapy @ (August 2018 - April 2020)
Senior Director of Global Business Development @ (January 2017 - January 2018)
Director Of Business Development @ (November 2015 - June 2017)
Senior Biologist, Business Development Consultant @ Eli Lilly and Company (February 2009 - November 2015)
Sr Research Associate, Gene Therapy Production @ (August 2007 - February 2009)
Senior Research Associate @ (August 2005 - August 2007)
Research And Development Associate @ (June 2003 - August 2005)
Research And Development Associate @ GeneCare Molecular Genetics (June 1999 - May 2003)
John Leonard Education
USC Marshall School of Business
Master of Business Administration (MBA)
2012-2014
UC San Diego
Graduate Studies
2007-2009
North Carolina State University
Bachelor of Science - BS
1998-2003
John Leonard Skills
Adenovirus
Antibodies
Antibody Engineering
Antibody Humanization
Artificial Intelligence (AI)
Assay Development
BD&L
Biochemistry
Biologics
Biomarkers
Biopharmaceuticals
Biopharmaceutics
Biotechnology
Biotechnology Industry
Biotherapeutics
Bispecific Antibodies
Business Development
Business Development Consultancy
Business Development Strategy
Business Model Development
Business Model Innovation
Business Relationship Management
Business Strategy
Cancer
Cancer Biology
Cell
Cell Biology
Cell Therapy
Clinical Development
Commercial Development
Competitive Intelligence
Corporate Finance
Cross-Functional Team Building
Cross-functional Team Leadership
Customer Relationship Management (CRM)
DNA
Deal Development
Deal Structuring
Directed Evolution
Disruptive Technologies
Drug Development
Drug Discovery
Drug Metabolism
Due Diligence
Entomology
Execution
Financial Accumen
Financial Modeling
Fundraising
Gene Therapy
Genomics
Global Drug Development
Good Laboratory Practice (GLP)
Good Manufacturing Practice (GMP)
Healthcare
High Throughput Screening
Human Genetics
Immunology
In Vitro
In Vitro Diagnostics (IVD)
In Vivo
Intellectual Property Strategy
Lentivirus
Licensing Negotiations
Life Science Industry
Life Sciences
Lifesciences
Machine Learning
Marketing Strategy
Mergers & Acquisitions (M&A)
Molecular Biology
Monoclonal Antibodies
Mutagenesis
Negotiation
Neurology
Neuroscience
Oncology
Organizational Culture
Pharmacology
Portfolio Management
Pre-clinical Studies
Product Development
Protein Chemistry
Protein Expression
Protein Purification
Rare Diseases
Sales
Sales Management
Start-up Ventures
Stem Cell Therapy
Strategic Leadership
Strategic Partnerships
Strategic Planning
Strategy
Therapeutics
Transgenic Mice
Valuation
financial acumen
industrial dynamics
liscensing
Microsoft Office
Leadership
Marketing
Clinical Research
Yahoo
Design of Experiments
Operational Planning
Adoption
Expression
Candidate Selection
Face to Face
Commercialization
Licensing
San Diego
Executive Team
Market Analysis
Forming
RNA
Revenue
Business Planning
FIX Protocol
Market Mapping
Partnerships
Molecular
Supply Chain Management
Precise
Alternative Solutions
Spotlight
Production Management
FDA
Institutions
Rsv
Data Collection
Investments
Silica
Proposal Writing
Microsoft Word
Stability
in Situ Hybridization
Applications
Portfolio
Design
Indications
International
Los Angeles
Offerings
Parkinson's
Editing
Receptors
Law Firms
Gene Expression
Virtual
Reports
Data Storage
Finance
Robust
Operations
Analysis
Quantifying
Pharmaceutical Industry
LinkedIn
Viewpoint
Sales and Marketing
Executive Positions
Searches
Investigational New Drug
Forecasting
Bioengineering
Dyslipidemia
Autoimmunity
Natural Products
Staining
Statistics
Research Institutes
Cros
Measurements
Business Insights
Materials
Implications
Management
Tissue
Business Analysis
Clinical Trials
Robotics
Cell Lines
Pricing
Business Partnering
Scientific
Pipelines
GMP
Profiles
Pharmaceutics
Diagnostics
Scientists
GLP
Sensitivity
Competitive Analysis
Strategies
Refining
Networking
Stakeholders
ISIS
Flu
Throat
Science
Mergers and Acquisitions
Bone
Responsibility
Patents
Industry Research
Synthesizing
Innovator
Presentations
ADCs
Nih
Commercial Real Estate
Small Molecules
Financial Advisory
Consulting
Business Case
Calcium
Infectious Diseases
Toxicology
Neurodegenerative Disease
Programming
CRO
Themes
Space
Risk
R&d
Genetics
Brand Awareness
Composition
Landscaping
Liquidity Events
Strategic Business
Central Nervous System
Medical Research
Technology Transfer
Research
Tests
Training
Web Marketing
Karyotyping
Policy
Advertising
Medical Genetics
Conceptual Modeling
Connecting
Therapists
Business Administration
Start Ups
New Opportunities
Testing
Contractual Agreements
Regulations
SAS
Corporate Development
Business Services
Patient
Medical Diagnostics
qPCR
Investor Relations
Encompassing
Nonprofits
Phase Ii
Efficient
Combination
Technical Marketing
Data Mapping
JMP
Written Communication
Software
Entrepreneurship
John Leonard Summary
John Leonard, based in San Diego, CA, US, is currently a Principal, Strategic Advisory at Leading Edge Bio. John Leonard brings experience from previous roles at The Jackson Laboratory, Protabit, HUYABIO International and Denovo Biopharma. John Leonard holds a 2012 - 2014 Master of Business Administration (MBA) @ USC Marshall School of Business. With a robust skill set that includes Adenovirus, Antibodies, Antibody Engineering, Antibody Humanization, Artificial Intelligence (AI) and more. John Leonard has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different John Leonard?
Find contact details for 700 million professionals.